Benzinga | Jan 5, 2022 08:41AM EST

Morgan Stanley Maintains Equal-Weight on Avrobio, Lowers Price Target to $3

Morgan Stanley analyst Michael Ulz maintains Avrobio (NASDAQ:AVRO) with a Equal-Weight and lowers the price target from $7 to $3.